It’s time for a better solution
Someday we may be able to predict heart failure events weeks before they happen.
Someday clinicians will be able to intervene earlier and help reduce patient hospitalizations.
Someday an actionable alert will help enable proactive care instead of reactive treatment.
That someday is today. With HeartLogic™ Heart Failure Diagnostic.*
*The HeartLogic Heart Failure Diagnostic is a validated diagnostic tool to detect gradual worsening of heart failure (HF) over days or weeks using multiple physiologic measurements.
How to Manage Heart Failure in the Real World with HeartLogicTM
John Boehmer, MD, Heart Failure Program Director, Penn State Hershey Heart and Vascular Institute, discusses the potential impact of HeartLogicTM on real-world cases at AAHFN 2018.
HeartLogicTM Heart Failure Diagnostic and Risk Stratification
Jagmeet Singh, MD, PhD, Associate Chief of Cardiology, Massachusetts General Hospital, discusses the benefits of HeartLogicTM Heart Failure Diagnostic as it relates to risk stratification of patients.
The HeartLogicTM Story
Hear the story behind the design of HeartLogicTM and its potential impact on patient care from the perspectives of clinicians and key experts from Boston Scientific.
|A promising step beyond current approaches, HeartLogic is a diagnostic tool that includes a composite index monitored over time and is designed to deliver proactive alerts of worsening heart failure to clinicians.|
|Multiple sensors track key physiological trends related to heart failure from within a high voltage Resonate™ family device.|
|HeartLogic combines these trends into one composite index.|
|Once the composite index crosses a programmable, clinician-set threshold, heart failure following clinicians are sent a proactive alert and given access to a detailed report. This is the information that your patient’s care team needs to know, before they’d expect to know it.|
|Multiple physiological sensors. One great choice for patients.
Our algorithm was designed to detect the early warning signs of worsening heart failure from a diverse set of sensors chosen to target the different aspects of heart failure pathology.
The choice you make now could help your heart failure patients in the future.
Choosing to implant a high voltage Resonate™ family device is the first step in helping you move from reactive treatment to proactive care for your patients with heart failure. Why wouldn’t you choose a device that is HeartLogic compatible?
CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labelling supplied with each device. Information for use only in countries with applicable health authority registrations. This material not intended for use in France.